Trials / Completed
CompletedNCT04254211
Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR
Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in Endovascular Aneurysm Repair for Abdominal Aorticaneurysm
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 230 (actual)
- Sponsor
- University of Thessaly · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study investigated the association of chronic inflammatory markers with the clinical outcome after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm.
Detailed description
The study included 230 consecutive AAA patients, treated electively by EVAR from March 2016 to February 2019. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively.Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NLR | neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2019-02-01
- Completion
- 2019-11-01
- First posted
- 2020-02-05
- Last updated
- 2021-04-28
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT04254211. Inclusion in this directory is not an endorsement.